Organization
ArQule, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
ArQule, Inc.
... ArQule, Inc. (Nasdaq: ARQL) today announced dosing of the initial patients in a registrational ...
... ECYT), Celldex Therapeutics, Inc. (NASDAQ: CLDX), CASI Pharmaceuticals Inc. (NASDAQ: CASI), ArQule, Inc. (NASDAQ: ARQL) A technology category that is projected to be the biggest ...
... ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the third quarter of ...
... ArQule, Inc. (NASDAQ: ARQL) today announced the closing of a private placement with institutional ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that the U.S. Food and Drug Administration (FDA) ...
... ArQule , Inc. (Nasdaq: ARQL) today announced it will report financial results for the third ...
... ArQule, Inc. (NASDAQ: ARQL) today announced the closing of a private placement with certain ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. ...
... ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the second quarter of ...
... ArQule , Inc. (Nasdaq: ARQL) today announced it will report financial results for the second ...
... ArQule, Inc. has announced that the first patient has been dosed in a ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that the first patient has been dosed in ...
... breach of fiduciary duty claim involving the board of directors of ArQule, Inc. (NASDAQ: ARQL). If you are a shareholder of ArQule, Inc. and are ...
... ArQule, Inc. has presented preclinical data for ARQ 531 in diffuse large B-cell ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that the first patient has been dosed in ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that data from a phase 1/2 trial with ...
... GmbH, Altor BioScience Corp, Ambrx Inc, amcure GmbH, Amgen Inc, arGEN-X BV, ArQule Inc, Array BioPharma Inc, Aspyrian Therapeutics Inc, Astellas Pharma Inc, AstraZeneca Plc, ...
... ArQule, Inc. has announced that it will present preclinical data for ARQ 531 ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that preclinical data for ARQ 531 in diffuse ...
... ArQule, Inc. (Nasdaq: ARQL) today announced that data from the phase 1/2 trial in ...
... ArQule , Inc. (Nasdaq: ARQL) today announced its financial results for the first quarter of ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤